SCHEMBL4016540

SCHEMBL4016540

Nc1ccc(CCCCCCCCCc2ccc(N)cc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.76
GFER P55789 1/20 0.72
MAOA P21397 2/20 0.59
HTR2A P28223 2/20 0.56
ALDH1A1 P00352 2/20 0.55
CYP3A4 P08684 1/20 0.55
TSHR P16473 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
LOXL2 Q9Y4K0 1/20 0.52
CYP19A1 P11511 2/20 0.50
RECQL P46063 1/20 0.48
MEN1 O00255 2/20 0.47
MAPT P10636 2/20 0.47
KMT2A Q03164 2/20 0.47
SIGMAR1 Q99720 1/20 0.47
KDM4E B2RXH2 1/20 0.46
USP2 O75604 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4020067 1.00 MAOB (0.76) MAOBGFERMAOAHTR2AALDH1A1
SCHEMBL4022346 1.00 MAOB (0.76) MAOBGFERMAOAHTR2AALDH1A1
SCHEMBL4020173 1.00 MAOB (0.76) MAOBGFERMAOAHTR2AALDH1A1
SCHEMBL4016462 1.00 MAOB (0.76) MAOBGFERMAOAHTR2AALDH1A1
SCHEMBL20251158 1.00 MAOB (0.76) MAOBGFERMAOAHTR2AALDH1A1
SCHEMBL4021564 1.00 MAOB (0.76) MAOBGFERMAOAHTR2AALDH1A1
SCHEMBL12110807 0.97 MAOB (0.73) MAOBGFERMAOAHTR2AALDH1A1
SCHEMBL12110805 0.97 MAOB (0.73) MAOBGFERMAOAHTR2AALDH1A1
SCHEMBL12110719 0.97 MAOB (0.73) MAOBGFERMAOAHTR2AALDH1A1
SCHEMBL12110815 0.97 GFER (0.78) MAOBGFERMAOAHTR2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119620472-A Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same 日产化学株式会社 2025-03-14 CN claimed
US-20260035513-A1 RESIN COMPOSITION, REINFORCED COMPOSITE MATERIAL, SHAPED PRODUCT, AND METHOD OF RECOVERING REINFORCING FIBER FROM REINFORCED COMPOSITE MATERIAL ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-02-05 US disclosed
EP-4578892-A1 RESIN COMPOSITION, COMPOSITE REINFORCING MATERIAL, MOLDED BODY, AND METHOD FOR RECOVERING REINFORCING FIBERS FROM COMPOSITE REINFORCING MATERIAL Asahi Kasei Kabushiki Kaisha (JP) 2025-07-02 EP disclosed
CN-119620472-A Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same 日产化学株式会社 2025-03-14 CN disclosed
CN-112764274-B Varnish for photo-alignment film and liquid crystal display device 株式会社日本显示器 2024-07-02 CN disclosed
WO-2024043285-A1 RESIN COMPOSITION, COMPOSITE REINFORCING MATERIAL, MOLDED BODY, AND METHOD FOR RECOVERING REINFORCING FIBERS FROM COMPOSITE REINFORCING MATERIAL 旭化成株式会社 2024-02-29 WO disclosed
US-20220315703-A1 VARNISH FOR PHOTO ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE JAPAN DISPLAY INC. (JP) 2022-10-06 US disclosed
US-11456184-B2 Substrate processing method and substrate processing system TOKYO ELECTRON LIMITED (JP) 2022-09-27 US disclosed
US-11384204-B2 Varnish for photo alignment film and liquid crystal display device JAPAN DISPLAY INC. (JP) 2022-07-12 US disclosed
CN-110554537-B Varnish for photo-alignment film and liquid crystal display device 株式会社日本显示器 2022-05-10 CN disclosed
US-20170137667-A1 VARNISH FOR PHOTO ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE JAPAN DISPLAY INC. (JP) 2017-05-18 US disclosed
US-9459494-B2 Liquid crystal aligning agent and liquid crystal display device employing it NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-10-04 US disclosed
US-9447240-B2 Polyimide precursor modified with dicarboxylic acid anhydride, imidized polyimide and liquid crystal aligning agent using it NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-09-20 US disclosed
US-20140226116-A1 LIQUID CRYSTAL DISPLAY AND METHOD FOR PRODUCING LIQUID CRYSTAL DISPLAY JSR CORPORATION (JP) 2014-08-14 US disclosed
US-20140066590-A1 POLYIMIDE PRECURSOR MODIFIED WITH DICARBOXYLIC ACID ANHYDRIDE, IMIDIZED POLYIMIDE AND LIQUID CRYSTAL ALIGNING AGENT USING IT NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-03-06 US disclosed
US-20140023798-A1 LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY DEVICE EMPLOYING IT NISSAN CHEMICAL INDUSTRIES LIMITED (JP) 2014-01-23 US disclosed
US-20090220707-A1 LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY DEVICE EMPLOYING IT NISSAN CHEMICAL INDUSTRIES LIMITED (JP) 2009-09-03 US disclosed
US-7498068-B2 Liquid-crystal aligning agent, liquid-crystal alignment film comprising the same, and liquid-crystal element NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2009-03-03 US disclosed
US-20070224370-A1 Liquid-Crystal Aligning Agent, Liquid-Crystal Alignment Film Comprising the Same, and Liquid-Crystal Element NISSAN CHEMICALS INDUSTRIES, LTD. (JP) 2007-09-27 US disclosed
US-20060142538-A1 Liquid crystal orientating agent and liquid crystal display element using it NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2006-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140066590-A1 POLYIMIDE PRECURSOR MODIFIED WITH DICARBOXYLIC ACID ANHYDRIDE, IMIDIZED POLYIMIDE AND LIQUID CRYSTAL ALIGNING AGENT USING IT CCDC22, RCC1, MACF1 MAOB 4432/4885GFER 1742/4885MAOA 4410/4885
US-20260035513-A1 RESIN COMPOSITION, REINFORCED COMPOSITE MATERIAL, SHAPED PRODUCT, AND METHOD OF RECOVERING REINFORCING FIBER FROM REINFORCED COMPOSITE MATERIAL TAF1, TAF1L, TAF9 MAOB 2358/4885GFER 833/4885MAOA 1110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.